What's New Digest - July 28, 2011

[Guest guest]

What's New Digest - July 28, 2011

News and Reports: www.lymphomation.org/current.htm

OR www.facebook.com/lymphomation.PAL (requires facebook account)

== Survivorship

ASCO: Making e-visits work for cancer patients

Planning 'Worry Time' May Help Ease Anxiety

Doctors Differ in How Best to Care for America's 12 Million Cancer Survivors

On Chemo brain: Fog May Be From Cancer, Not the Chemo

Some supplements claim that they " boost the immune system. " Is this a

reasonable claim?

Stay safe in the ER with life-saving strategies - As many as 98,000

Americans die every year as a result of medical mistakes

Seeking Serenity: Serious illness won’t get off my back

== Reports / Background

The epidemiology of NHL

Oral fludarabine and Rituxan as initial therapy for CLL/SLL:

population-based experience matches clinical trials.

Lenalidomide associated with durable remissions in elderly patients with

symptomatic CLL

2 genetic variations predict second cancers after radiation for children

with Hodgkin lymphoma

Rituximab and/or Lenalidomide in Treating Patients With Follicular NHL That

is Not Refractory to Rituximab

Lenalidomide and Rituxan in Treating Patients With Previously Untreated

Stage II, Stage III, or Stage IV Follicular NHL

Treatment Options for Peripheral T-cell lymphoma

Evolving Therapy of Peripheral T-cell Lymphoma 2010 and Beyond

Cutaneous Lymphoma Patient Educational Opportunities

Combo Regimen Advised as 2nd-Line Therapy for Waldenstrom's

Macroglobulinemia

Maintenance Rituxan associated with improved clinical outcome in rituxan

naïve Waldenstrom Macroglobulinaemia who respond to a rituxan-containing

regimen

==Food for Thought

Are Cancers Newly Evolved Species?

New Cancer Treatment? Universal Donor Immune Cells

Immunotherapy: Past, Present and Future

==Technical items

Preclinical: Scientists Strike Genetic Gold in Lymphoma Study

Specialized Regulatory T Cell Stifles Antibody Production Centers

<http://bit.ly/q9yAp>

Histone modifying genes play a role in non-Hodgkin's lymphoma

Research on tumor microenvironment - Monocytes and T cells cooperate to

favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L

signaling

Pitfalls in lymphoma pathology: avoiding errors in diagnosis of lymphoid

tissues

==Clinical Trials or Agents of Interest

TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell

Lymphomas

Waldenström's studies

Recent and additional trials of interest based on clinical circumstances

==PAL Updates

Tips for Minimizing Anxiety and Pain during blood draws and IV preparations

PET scan - clinical use of: " very little is certain and agreed upon. "

To open the above items, go to:

News and Reports: www.lymphomation.org/current.htm

OR www.facebook.com/lymphomation.PAL (requires facebook account)

Karl

Patients Against Lymphoma

www.lymphomation.org